VEGFC and macular degeneration: There is considerable interest in therapeutically targeting VEGF-C and/or VEGF-D in the clinic to block their action and thereby restrict angiogenesis, lymphangiogenesis, or vascular leakage in cancer, macular degeneration, and other conditions (9, 50, –, 53).